| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-12 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |